http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0495013-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6699e8a56c561f2a2c2f38b1f0cc1412 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-5955 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-595 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-595 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
| filingDate | 1990-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d5a5dcd3200decfd4422a7ddef365e3 |
| publicationDate | 1992-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0495013-A1 |
| titleOfInvention | HEXAPEPTIDES WITH SULPHATE ESTER GROUPS. |
| abstract | The compounds of formula (I), in which M represents Met, DMet, MeMet, MetO, Ahx, DAhx, MeAhx, Leu, MeLeu, Pro, Ile, MeIle, Ala or Ly; G represents Gly, DAla, Pro, Ala, betaAla or Sar; W represents Trp, MeTrp, Ala or Nal; X represents Met, MeMet, MetO, Ahx, MeAhx, Leu, MeLeu, Pro, Ile, MeIle, Ala or Lys; J represents Asp, DAsp, MeAsp, Ala or Asn; F1 represents (S) -NH, (R) -NH, (S) -R1N or (R) -R2N; F2 represents H, Cl, I, Br, F, NO2, NH2, R3 or OR4; Z represents NH2, NHR5 or NR5R6; R1, R2, R3, R5 and R6 represents alkyl containing 1 to 6 carbon atoms; and R4 represents H or alkyl containing 1 to 6 carbon atoms; as well as their pharmaceutically acceptable salts, constitute new and useful pharmaceutical products. They are particularly useful in the treatment of obesity, and in stimulating the contraction of the gallbladder. |
| priorityDate | 1989-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 216.